NCM
Nantahala Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.07M | Buy |
754,503
+200,000
| +36% | +$1.87M | 0.28% | 58 |
|
|
2025
Q1 | $6.81M | Sell |
554,503
-6,029
| -1% | -$74.1K | 0.27% | 47 |
|
|
2024
Q4 | $7.41M | Buy |
560,532
+107,300
| +24% | +$1.42M | 0.32% | 51 |
|
|
2024
Q3 | $8.72M | Hold |
453,232
| – | – | 0.44% | 36 |
|
|
2024
Q2 | $9.3M | Sell |
453,232
-12,027
| -3% | -$247K | 0.54% | 30 |
|
|
2024
Q1 | $11.1M | Buy |
465,259
+100,000
| +27% | +$2.38M | 0.63% | 26 |
|
|
2023
Q4 | $7.89M | Buy |
365,259
+125,228
| +52% | +$2.71M | 0.47% | 40 |
|
|
2023
Q3 | $3.49M | Sell |
240,031
-83,103
| -26% | -$1.21M | 0.3% | 61 |
|
|
2023
Q2 | $6.76M | Sell |
323,134
-652,571
| -67% | -$13.7M | 0.65% | 32 |
|
|
2023
Q1 | $20.6M | Hold |
975,705
| – | – | 1.58% | 15 |
|
|
2022
Q4 | $24.8M | Sell |
975,705
-399,723
| -29% | -$10.2M | 1.61% | 11 |
|
|
2022
Q3 | $33.1M | Sell |
1,375,428
-1,287,659
| -48% | -$30.9M | 2.14% | 8 |
|
|
2022
Q2 | $51.2M | Sell |
2,663,087
-29,216
| -1% | -$562K | 2.57% | 4 |
|
|
2022
Q1 | $46.8M | Sell |
2,692,303
-158,256
| -6% | -$2.75M | 2.07% | 11 |
|
|
2021
Q4 | $62.4M | Buy |
2,850,559
+193,400
| +7% | +$4.23M | 2.2% | 4 |
|
|
2021
Q3 | $50.8M | Buy |
2,657,159
+63,822
| +2% | +$1.22M | 1.6% | 10 |
|
|
2021
Q2 | $44.5M | Buy |
2,593,337
+590,927
| +30% | +$10.1M | 1.27% | 11 |
|
|
2021
Q1 | $44.8M | Buy |
2,002,410
+203,957
| +11% | +$4.56M | 1.31% | 12 |
|
|
2020
Q4 | $40M | Buy |
1,798,453
+459,762
| +34% | +$10.2M | 1.24% | 13 |
|
|
2020
Q3 | $19.8M | Buy |
+1,338,691
| New | +$19.8M | 0.6% | 26 |
|